27
Views
2
CrossRef citations to date
0
Altmetric
Review

Leber’s hereditary optic neuropathy: new quinone therapies change the paradigm

, &
Pages 251-259 | Published online: 09 Jan 2014

References

  • Leber T. [On hereditary and congenital optic neuropathies]. Arch. Fur. Ophthalmologie (17), 249–291 (1871).
  • Wallace DC, Singh G, Lott MT et al. Mitochondrial DNA mutation associated with Leber’s hereditary optic neuropathy. Science242(4884), 1427–1430 (1988).
  • Carelli V, Ross-Cisneros FN, Sadun AA. Mitochondrial dysfunction as a cause of optic neuropathies. Prog. Retin. Eye Res.23(1), 53–89 (2004).
  • Fraser JA, Biousse V, Newman NJ. The neuro-ophthalmology of mitochondrial disease. Surv. Ophthalmol.55(4), 299–334 (2010).
  • Yu-Wai-Man P, Griffiths PG, Chinnery PF. Mitochondrial optic neuropathies – disease mechanisms and therapeutic strategies. Prog. Retin. Eye Res.30(2), 81–114 (2011).
  • Shah VA, Randhawa S, Mizen T, Lee AG, Foroozan R. You’re too old for that. Surv. Ophthalmol.53(4), 403–410 (2008).
  • Barboni P, Savini G, Valentino ML et al. Leber’s hereditary optic neuropathy with childhood onset. Invest. Ophthalmol .Vis. Sci.47(12), 5303–5309 (2006).
  • Nikoskelainen EK, Huoponen K, Juvonen V et al. Ophthalmologic findings in Leber hereditary optic neuropathy, with special reference to mtDNA mutations. Ophthalmology103(3), 504–514 (1996).
  • Spruijt L, Kolbach DN, de Coo RF et al. Influence of mutation type on clinical expression of Leber hereditary optic neuropathy. Am. J. Ophthalmol.141(4), 676–682 (2006).
  • Carelli V, La Morgia C, Valentino ML et al. Idebenone treatment in Leber’s hereditary optic neuropathy. Brain134(Pt 9), E188 (2011).
  • La Morgia C, Ross-Cisneros FN, Sadun AA et al. Melanopsin retinal ganglion cells are resistant to neurodegeneration in mitochondrial optic neuropathies. Brain133(Pt 8), 2426–2438 (2010).
  • Sadun F, De Negri AM, Carelli V et al. Ophthalmologic findings in a large pedigree of 11778/Haplogroup J Leber hereditary optic neuropathy. Am. J. Ophthalmol.137(2), 271–277 (2004).
  • Ventura DF, Quiros P, Carelli V et al. Chromatic and luminance contrast sensitivities in asymptomatic carriers from a large Brazilian pedigree of 11778 Leber hereditary optic neuropathy. Invest. Ophthalmol. Vis. Sci.46(12), 4809–4814 (2005).
  • Ventura DF, Gualtieri M, Oliveira AG et al. Male prevalence of acquired color vision defects in asymptomatic carriers of Leber’s hereditary optic neuropathy. Invest. Ophthalmol. Vis. Sci.48(5), 2362–2370 (2007).
  • Sacai PY, Salomao SR, Carelli V et al. Visual evoked potentials findings in non-affected subjects from a large Brazilian pedigree of 11778 Leber’s hereditary optic neuropathy. Doc. Ophthalmol.121(2), 147–154 (2010).
  • Savini G, Barboni P, Valentino ML et al. Retinal nerve fiber layer evaluation by optical coherence tomography in unaffected carriers with Leber’s hereditary optic neuropathy mutations. Ophthalmology112(1), 127–131 (2005).
  • Sadun AA, Salomao SR, Berezovsky A et al. Subclinical carriers and conversions in Leber hereditary optic neuropathy: a prospective psychophysical study. Trans. Am. Ophthalmol. Soc.104, 51–61 (2006).
  • Barboni P, Carbonelli M, Savini G et al. Natural history of Leber’s hereditary optic neuropathy: longitudinal analysis of the retinal nerve fiber layer by optical coherence tomography. Ophthalmology117(3), 623–627 (2010).
  • Ramos Cdo V, Bellusci C, Savini G et al. Association of optic disc size with development and prognosis of Leber’s hereditary optic neuropathy. Invest. Ophthalmol. Vis. Sci.50(4), 1666–1674 (2009).
  • Nikoskelainen EK, Marttila RJ, Huoponen K et al. Leber’s ‘plus’: neurological abnormalities in patients with Leber’s hereditary optic neuropathy. J. Neurol. Neurosurg. Psychiatry59(2), 160–164 (1995).
  • Harding AE, Sweeney MG, Miller DH et al. Occurrence of a multiple sclerosis-like illness in women who have a Leber’s hereditary optic neuropathy mitochondrial DNA mutation. Brain115(Pt 4), 979–989 (1992).
  • La Morgia C, Achilli A, Iommarini L et al. Rare mtDNA variants in Leber hereditary optic neuropathy families with recurrence of myoclonus. Neurology70(10), 762–770 (2008).
  • Sadun AA, Win PH, Ross-Cisneros FN, Walker SO, Carelli V. Leber’s hereditary optic neuropathy differentially affects smaller axons in the optic nerve. Trans. Am. Ophthalmol. Soc.98, 223–223 (2000).
  • Sadun AA, Carelli V, Salomao SR et al. Extensive investigation of a large Brazilian pedigree of 11778/haplogroup J Leber hereditary optic neuropathy. Am. J. Ophthalmol.136(2), 231–238 (2003).
  • Carelli V, Achilli A, Valentino ML et al. Haplogroup effects and recombination of mitochondrial DNA: novel clues from the analysis of Leber hereditary optic neuropathy pedigrees. Am. J. Hum. Genet.78(4), 564–574 (2006).
  • Hudson G, Carelli V, Spruijt L et al. Clinical expression of Leber hereditary optic neuropathy is affected by the mitochondrial DNA-haplogroup background. Am. J. Hum. Genet.81(2), 228–233 (2007).
  • Yang J, Zhu Y, Tong Y et al. The novel G10680A mutation is associated with complete penetrance of the LHON/T14484C family. Mitochondrion9(4), 273–278 (2009).
  • Howell N, Mackey DA. Low-penetrance branches in matrilineal pedigrees with Leber hereditary optic neuropathy. Am. J. Hum. Genet.63(4), 1220–1224 (1998).
  • Chuenkongkaew WL, Suphavilai R, Vaeusorn L, Phasukkijwatana N, Lertrit P, Suktitipat B. Proportion of 11778 mutant mitochondrial DNA and clinical expression in a Thai population with leber hereditary optic neuropathy. J. Neuroophthalmol.25(3), 173–175 (2005).
  • Howell N, Kubacka I, Xu M, McCullough DA. Leber hereditary optic neuropathy: involvement of the mitochondrial ND1 gene and evidence for an intragenic suppressor mutation. Am. J. Hum. Genet.48(5), 935–942 (1991).
  • Howell N, Xu M, Halvorson S, Bodis-Wollner I, Sherman J. A heteroplasmic LHON family: tissue distribution and transmission of the 11778 mutation. Am. J. Hum. Genet.55(1), 203–206 (1994).
  • Carelli V, Giordano C, d’Amati G. Pathogenic expression of homoplasmic mtDNA mutations needs a complex nuclear-mitochondrial interaction. Trends Genet.19(5), 257–262 (2003).
  • Kirkman MA, Yu-Wai-Man P, Korsten A et al. Gene–environment interactions in Leber hereditary optic neuropathy. Brain132(Pt 9), 2317–2326 (2009).
  • Harding AE, Sweeney MG, Govan GG, Riordan-Eva P. Pedigree analysis in Leber hereditary optic neuropathy families with a pathogenic mtDNA mutation. Am. J. Hum. Genet.57(1), 77–86 (1995).
  • Hudson G, Keers S, Yu Wai Man P et al. Identification of a X-chromosomal locus and haplotype modulating the phenotype of a mitochondrial DNA disorder. Am. J. Hum. Genet.77(6), 1086–1091 (2005).
  • Shankar SP, Fingert JH, Carelli V et al. Evidence for a novel x-linked modifier locus for Leber hereditary optic neuropathy. Ophthalmic Genet.29(1), 17–24 (2008).
  • Ji Y, Jia X, Li S, Xiao X, Guo X, Zhang Q. Evaluation of the X-linked modifier loci for Leber hereditary optic neuropathy with the G11778A mutation in Chinese. Mol. Vis.16, 416–424 (2010).
  • Giordano C, Montopoli M, Perli E et al. Oestrogens ameliorate mitochondrial dysfunction in Leber’s hereditary optic neuropathy. Brain134(Pt 1), 220–234 (2011).
  • Phasukkijwatana N, Kunhapan B, Stankovich J et al. Genome-wide linkage scan and association study of PARL to the expression of LHON families in Thailand. Hum. Genet.128(1), 39–49 (2010).
  • Zhang AM, Jia X, Zhang Q, Yao YG. No association between the SNPs (rs3749446 and rs1402000) in the PARL gene and LHON in Chinese patients with m.11778G>A. Hum. Genet.128(4), 465–468 (2010).
  • Hudson G, Yu-Wai-Man P, Griffiths PG et al. Variation in OPA1 does not explain the incomplete penetrance of Leber hereditary optic neuropathy. Mol. Vis.16, 2760–2764 (2010).
  • Hudson G, Yu-Wai-Man P, Griffiths PG et al. Variation in MAPT is not a contributing factor to the incomplete penetrance in LHON. Mitochondrion11(4), 620–622 (2011).
  • Baracca A, Solaini G, Sgarbi G et al. Severe impairment of complex I-driven adenosine triphosphate synthesis in leber hereditary optic neuropathy cybrids. Arch. Neurol.62(5), 730–736 (2005).
  • Beretta S, Mattavelli L, Sala G et al. Leber hereditary optic neuropathy mtDNA mutations disrupt glutamate transport in cybrid cell lines. Brain127(Pt 10), 2183–2192 (2004).
  • Floreani M, Napoli E, Martinuzzi A et al. Antioxidant defences in cybrids harboring mtDNA mutations associated with Leber’s hereditary optic neuropathy. FEBS J.272(5), 1124–1135 (2005).
  • Ghelli A, Zanna C, Porcelli AM et al. Leber’s hereditary optic neuropathy (LHON) pathogenic mutations induce mitochondrial-dependent apoptotic death in transmitochondrial cells incubated with galactose medium. J. Biol. Chem.278(6), 4145–4150 (2003).
  • Zanna C, Ghelli A, Porcelli AM, Martinuzzi A, Carelli V, Rugolo M. Caspase-independent death of Leber’s hereditary optic neuropathy cybrids is driven by energetic failure and mediated by AIF and Endonuclease G. Apoptosis10(5), 997–1007 (2005).
  • Porcelli AM, Angelin A, Ghelli A et al. Respiratory complex I dysfunction due to mitochondrial DNA mutations shifts the voltage threshold for opening of the permeability transition pore toward resting levels. J. Biol. Chem.284(4), 2045–2052 (2009).
  • Carelli V, Rugolo M, Sgarbi G et al. Bioenergetics shapes cellular death pathways in Leber’s hereditary optic neuropathy: a model of mitochondrial neurodegeneration. Biochim. Biophys. Acta1658(1–2), 172–179 (2004).
  • Barboni P, Savini G, Valentino ML et al. Retinal nerve fiber layer evaluation by optical coherence tomography in Leber’s hereditary optic neuropathy. Ophthalmology112(1), 120–126 (2005).
  • Sadun AA, Wang MY. Abnormalities of the optic disc. Handb. Clin. Neurol.102, 117–157 (2011).
  • Bloom SM, Merz EH, Taylor WW. Nutritional amblyopia in American prisoners of war liberated from the Japanese. Am. J. Ophthalmol.29, 1248–1257 (1946).
  • Hsu CT, Miller NR, Wray ML. Optic neuropathy from folic acid deficiency without alcohol abuse. Ophthalmologica216(1), 65–67 (2002).
  • Godel V, Nemet P, Lazar M. Chloramphenicol optic neuropathy. Arch. Ophthalmol.98, 1417–1421 (1980).
  • Sadun AA, Wang MY. Ethambutol optic neuropathy: how we can prevent 100,000 new cases of blindness each year. J. Neuroophthalmol.28(4), 265–268 (2008).
  • Javaheri M, Khurana RN, O’Hearn TM, Lai MM, Sadun AA. Linezolid-induced optic neuropathy: a mitochondrial disorder? Br. J. Ophthalmol.91(1), 111–115 (2007).
  • Kerrison JB, Miller NR, Hsu F et al. A case–control study of tobacco and alcohol consumption in Leber hereditary optic neuropathy. Am. J. Ophthalmol.130(6), 803–812 (2000).
  • Sanchez RN, Smith AJ, Carelli V et al. Leber hereditary optic neuropathy possibly triggered by exposure to tire fire. J. Neuroophthalmol.26(4), 268–272 (2006).
  • Sadun AA, La Morgia C, Carelli V. Leber’s hereditary optic neuropathy. Curr. Treat. Options Neurol.13(1), 109–117 (2011).
  • Newman NJ, Biousse V, David R et al. Prophylaxis for second eye involvement in leber hereditary optic neuropathy: an open-labeled, nonrandomized multicenter trial of topical brimonidine purite. Am. J. Ophthalmol.140(3), 407–415 (2005).
  • Geromel V, Darin N, Chrétien D et al. Coenzyme Q(10) and idebenone in the therapy of respiratory chain diseases: rationale and comparative benefits. Mol. Genet. Metab.77(1–2), 21–30 (2002).
  • Mashima Y, Kigasawa K, Wakakura M, Oguchi Y. Do idebenone and vitamin therapy shorten the time to achieve visual recovery in Leber hereditary optic neuropathy? J. Neuroophthalmol.20(3), 166–170 (2000).
  • Sabet-Peyman EJ, Khaderi KR, Sadun AA. Is leber hereditary optic neuropathy treatable? encouraging results with idebenone in both prospective and retrospective trials and an illustrative case. J. Neuroophthalmol.32(1), 54–57 (2012).
  • Klopstock T, Yu-Wai-Man P, Dimitriadis K et al. A randomized placebo-controlled trial of idebenone in Leber’s hereditary optic neuropathy. Brain134(Pt 9), 2677–2686 (2011).
  • Newman NJ. Treatment of Leber hereditary optic neuropathy. Brain134(Pt 9), 2447–2450 (2011).
  • Shrader WD, Amagata A, Barnes A et al. α-tocotrienol quinone modulates oxidative stress response and the biochemistry of aging. Bioorg. Med. Chem. Lett.21(12), 3693–3698 (2011).
  • Enns GM, Kinsman SL, Perlman SL et al. Initial experience in the treatment of inherited mitochondrial disease with EPI-743. Mol. Genet. Metab.105(1), 91–102 (2012).
  • Sadun AA, Chicani CF, Ross-Cisneros FN et al. Effect of EPI-743 on the clinical course of the mitochondrial disease Leber’s hereditary optic neuropathy. Arch. Neurol.69(3), 331–338 (2012).
  • Gray RE, Law RH, Devenish RJ, Nagley P. Allotopic expression of mitochondrial ATP synthase genes in nucleus of Saccharomyces cerevisiae. Methods Enzymol.264, 369–389 (1996).
  • Guy J, Qi X, Pallotti F, Schon EA et al. Rescue of a mitochondrial deficiency causing leber hereditary optic neuropathy. Ann. Neurol.52(5), 534–542 (2002).
  • Oca-Cossio J, Kenyon L, Hao H, Moraes CT. Limitations of allotopic expression of mitochondrial genes in mammalian cells. Genetics165(2), 707–720 (2003).
  • Perales-Clemente E, Fernández-Silva P, Acín-Pérez R, Pérez-Martos A, Enríquez JA. Allotopic expression of mitochondrial-encoded genes in mammals: achieved goal, undemonstrated mechanism or impossible task? Nucleic Acids Res.39(1), 225–234 (2011).
  • Ellouze S, Augustin S, Bouaita A et al. Optimized allotopic expression of the human mitochondrial ND4 prevents blindness in a rat model of mitochondrial dysfunction. Am. J. Hum. Genet.83(3), 373–387 (2008).
  • Lam BL, Feuer WJ, Abukhalil F, Porciatti V, Hauswirth WW, Guy J. Leber hereditary optic neuropathy gene therapy clinical trial recruitment: year 1. Arch. Ophthalmol.128(9), 1129–1135 (2010).
  • Koilkonda RD, Guy J. Leber’s hereditary optic neuropathy – gene therapy: from benchtop to bedside. J. Ophthalmol.2011, 179412 (2011).
  • Cwerman-Thibault H, Sahel JA, Corral-Debrinski M. Mitochondrial medicine: to a new era of gene therapy for mitochondrial DNA mutations. J. Inherit. Metab. Dis.34(2), 327–344 (2011).
  • Marella M, Seo BB, Thomas BB, Matsuno-Yagi A, Yagi T. Successful amelioration of mitochondrial optic neuropathy using the yeast NDI1 gene in a rat animal model. PLoS One5(7), E11472 (2010).
  • Iyer S, Bergquist K, Young K, Gnaiger E, Rao RR, Bennett JP Jr. Mitochondrial gene therapy improves respiration, biogenesis and transcription in G11778A Leber’s hereditary optic neuropathy and T8993G Leigh’s syndrome cells. Hum. Gene. Ther. doi:10.1089/hum.2011.177 (2012) (Epub ahead of print).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.